Publication:
Impact of older age on local treatment decisions

dc.contributor.authorsUgurlu, M. Umit; Gulluoglu, Bahadir M.
dc.date.accessioned2022-03-12T16:24:11Z
dc.date.accessioned2026-01-11T16:32:36Z
dc.date.available2022-03-12T16:24:11Z
dc.date.issued2019
dc.description.abstractManaging elderly breast cancer patients brings challenges both to physicians and patients themselves. There are certain controversial issues regarding local treatment of early breast cancer in this population. Since elderly patients are more likely to have comorbidities and functional limitations, they are more prone to undertreatment. Although surgical treatment in elderly patients were reported to be safe, severity and number of comorbidities are shown to be related with increased complications, hence may lead to higher mortality and lower life quality. Therefore, frailty is one of the concerns which prevents elderly patients to receive standard-of-care local treatment. Nevertheless, breast cancers developing in elderly are more likely to be low grade and luminal type. Until now, primary endocrine treatment without surgical resection, omitting whole breast irradiation after partial mastectomyand avoiding sentinel lymph node biopsy, which are otherwise accepted as standard-of-care, were questionned in healthy, low-risk, elderly fit patients. Two main issues were suggested to be considered when assessing the impact of local treatment options in this patient group; the clinical significance of treatments' effects, and the patients' expectations. Due to their vulnerability, baseline geriatric assessment should be the initial step for management in elderly breast cancer patients. Even in those who are healthy and fit with long life-expectancy, de-escalation in management might be an option in low-risk patients after considering patients' individual expectations and limited clinical benefits of standard local treatment options. (C) 2019 Elsevier Ltd. All rights reserved.
dc.identifier.doidoiWOS:000508178900013
dc.identifier.eissn1532-3080
dc.identifier.issn0960-9776
dc.identifier.pubmed31839162
dc.identifier.urihttps://hdl.handle.net/11424/226249
dc.identifier.wosWOS:000508178900013
dc.language.isoeng
dc.publisherCHURCHILL LIVINGSTONE
dc.relation.ispartofBREAST
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBreast cancer
dc.subjectElderly
dc.subjectLocal treatment
dc.subjectWhole breast irradiation
dc.subjectSentinel lymph node biopsy
dc.subjectPrimary endocrine treatment
dc.subjectBREAST-CANCER PATIENTS
dc.subjectEARLY-STAGE
dc.subjectRANDOMIZED-TRIAL
dc.subjectINTERNATIONAL SOCIETY
dc.subjectTREATMENT PREFERENCES
dc.subjectGERIATRIC ASSESSMENT
dc.subjectADJUVANT TAMOXIFEN
dc.subjectENDOCRINE THERAPY
dc.subjectCLINICAL-TRIALS
dc.subjectPLUS TAMOXIFEN
dc.titleImpact of older age on local treatment decisions
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS61
oaire.citation.startPageS57
oaire.citation.titleBREAST
oaire.citation.volume48

Files